Speaker: 

Nathan Field, DO-Pediatric Resident, Geisinger - has nothing to disclose.

Moderator: 

Frank Maffei, MD, Chair, Pediatrics, JWCH, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• review the microbiology and virulence factors of Group A streptococcus.
• summarize the burden of GAS infection in the US and worldwide.
• compare the trends in GAS disease before, during, and after the COVID-19 pandemic.
• describe the epidemiology, diagnosis, and current recommendations for treatment of GAS pharyngitis.
• develop strategies to trouble shoot and treat recurrent GAS pharyngitis.
• review strategies to prevent GAS infection, including the development of GAS specific vaccinations.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Frank Maffei, MD; Sarah Marks, MD; Amy Diehl, BSN, RN, CPN; Joan Keehan, RPH; Sandra Heller and Connie Winter have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant.